Predictive Clinical Features in Germline Testing for Renal Cell Carcinoma
Alexis Rompré‐Brodeur(National Cancer Institute), Mark W. Ball(Johns Hopkins University), Alexandra Lebensohn(National Institutes of Health), Cathy D. Vocke(National Cancer Institute), Jeunice Owens-Walton(National Cancer Institute), Michael Daneshvar(University of California, Irvine), Nikhil Gopal(University of Washington), Braden Millan(National Cancer Institute), Rabindra Gautam(National Institutes of Health), Deborah Nielsen(National Institutes of Health), Christopher J. Ricketts(National Cancer Institute), Laura S. Schmidt(Leidos (United States)), Beth Ryan(National Cancer Institute), Bradley R. Webster(University of New Mexico), W. Marston Linehan(National Institutes of Health), Kristin Choo(National Institutes of Health), Sandeep Gurram(National Institutes of Health)
Cited by 0
Related Papers
The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma
|Cancer Cell|2014|867
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
|Cell Reports|2018|818
Tumor risks and genotypeâphenotypeâproteotype analysis in 358 patients with germline mutations in<i>SDHB</i>and<i>SDHD</i>
|Human Mutation|2009|340
Identification of a molecular component of the mitochondrial acetyltransferase programme: a novel role for GCN5L1
|Biochemical Journal|2012|220